Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Day One Biopharmaceuticals (DAWN) Return on Equity: 2024-2025

Historic Return on Equity for Day One Biopharmaceuticals (DAWN) over the last 2 years, with Sep 2025 value amounting to -0.33%.

  • Day One Biopharmaceuticals' Return on Equity rose 12.00% to -0.33% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.33%, marking a year-over-year increase of 12.00%. This contributed to the annual value of -0.48% for FY2024, which is 7.00% up from last year.
  • Day One Biopharmaceuticals' Return on Equity amounted to -0.33% in Q3 2025, which was down 62.71% from -0.20% recorded in Q2 2025.
  • Day One Biopharmaceuticals' 5-year Return on Equity high stood at -0.20% for Q2 2025, and its period low was -0.91% during Q2 2024.
  • Its 2-year average for Return on Equity is -0.47%, with a median of -0.39% in 2024.
  • Data for Day One Biopharmaceuticals' Return on Equity shows a peak YoY surged of 71bps (in 2025) over the last 5 years.
  • Day One Biopharmaceuticals' Return on Equity (Quarterly) stood at -0.39% in 2024, then grew by 12bps to -0.33% in 2025.
  • Its last three reported values are -0.33% in Q3 2025, -0.20% for Q2 2025, and -0.36% during Q1 2025.